Nasdaq

Masimo : FDA Oks Pediatric Indication For SedLine Brain Function Monitoring And EEG Sensor

(RTTNews) - Masimo (MASI) said that the U.S. FDA has cleared SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG Sensor. With this clearance, the ...
Nasdaq

Masimo's (MASI) SedLine Receives FDA's Pediatric Indication

Masimo Corporation MASI recently received the FDA’s clearance for SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG (electroencephalogram) ...
Seeking Alpha

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

EEG-Guided Anesthesia Using Masimo Technology Significantly Reduced Pediatric Anesthesia Emergence Delirium, Time to Emergence and Discharge, and Cost of Care by Minimizing Sevoflurane Exposure ...
FierceBiotech

Masimo's brain-monitoring headset nabs FDA nod for use in kids

The SedLine sensors and monitoring system have now been adapted to fit children between the ages of 1 and 17. The system helps physicians monitor brain activity while patients are sedated, detecting ...